Huntington National Bank Charles River Laboratories International, Inc. Transaction History

Huntington National Bank

$13.5 Billion
Q3 2024

A detailed history of Huntington National Bank transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Huntington National Bank holds 136 shares of CRL stock, worth $26,624. This represents 0.0% of its overall portfolio holdings.

Number of Shares

136

Previous 247 44.94%

Holding current value

$26,624

Previous $51,000 49.02%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$187.96 - $245.29 $20,863 - $27,227	-111 Reduced 44.94%	136 $26,000
Q2 2024 Aug 08, 2024	SELL	$206.39 - $268.73 $619 - $806	-3 Reduced 1.2%	247 $51,000
Q1 2024 May 03, 2024	BUY	$203.52 - $273.43 $6,512 - $8,749	32 Added 14.68%	250 $67,000
Q4 2023 Feb 07, 2024	SELL	$164.52 - $238.84 $8,226 - $11,942	-50 Reduced 18.66%	218 $51,000
Q3 2023 Nov 08, 2023	SELL	$194.44 - $217.61 $14,194 - $15,885	-73 Reduced 21.41%	268 $52,000
Q2 2023 Aug 11, 2023	BUY	$183.71 - $210.25 $22,412 - $25,650	122 Added 55.71%	341 $71,000
Q1 2023 May 10, 2023	BUY	$191.89 - $259.92 $3,262 - $4,418	17 Added 8.42%	219 $44,000
Q4 2022 Feb 09, 2023	BUY	$197.11 - $250.07 $2,562 - $3,250	13 Added 6.88%	202 $43,000
Q3 2022 Nov 07, 2022	BUY	$182.44 - $250.54 $12,041 - $16,535	66 Added 53.66%	189 $37,000
Q2 2022 Aug 09, 2022	BUY	$204.13 - $302.4 $2,245 - $3,326	11 Added 9.82%	123 $26,000
Q1 2022 May 10, 2022	SELL	$255.51 - $362.11 $2,810 - $3,983	-11 Reduced 8.94%	112 $32,000
Q4 2021 Jan 21, 2022	SELL	$351.38 - $448.68 $351 - $448	-1 Reduced 0.81%	123 $46,000
Q3 2021 Oct 28, 2021	SELL	$372.64 - $458.3 $19,749 - $24,289	-53 Reduced 29.94%	124 $51,000
Q2 2021 Jul 30, 2021	BUY	$294.17 - $371.65 $16,179 - $20,440	55 Added 45.08%	177 $65,000
Q1 2021 Apr 12, 2021	BUY	$249.67 - $299.48 $16,727 - $20,065	67 Added 121.82%	122 $35,000
Q4 2020 Jan 11, 2021	BUY	$222.0 - $252.62 $11,988 - $13,641	54 Added 5400.0%	55 $14,000
Q2 2019 Jul 23, 2019	BUY	$123.4 - $148.55 $123 - $148	1 New	1 $0
Q1 2019 Apr 09, 2019	SELL	$104.82 - $146.73 $104 - $146	-1 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$112.11 - $134.54 $112 - $134	1 New	1 $0

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.96B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Account

Huntington National Bank Charles River Laboratories International, Inc. Transaction History